vestronidase alfa
Generic: vestronidase alfa·Brand: Mepsevii
vestronidase alfa: developed by 1 company · 1 clinical trial tracked.
vestronidase alfa evidence translation
What we can confirm
1 tracked trial
What it means
Source-backed records connect vestronidase alfa to RARE; that link alone does not prove the drug works.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
How could vestronidase alfa → RARE affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
MPS VII
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) MPS VII | Approved |
Clinical Trials (1)
Expanded Access to Mepsevii
Expanded AccessUltragenyx Pharmaceutical Inc
Frequently asked questions
Who is developing vestronidase alfa?
vestronidase alfa is being developed by Ultragenyx Pharmaceutical Inc..
How many clinical trials involve vestronidase alfa?
BioSniper tracks 1 clinical trial involving vestronidase alfa.